MedTrace Logo

The Shang Ring: A Novel Male Circumcision Device for HIV Prevention

NCT00993811 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-12-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Shang Ring, a novel Chinese device for voluntary medical male circumcision, in order to improve the provision of male circumcision services for HIV prevention in Africa.

Conditions

  • Male Circumcision
  • HIV Prevention
  • HIV Infections

Interventions

DEVICE

Shang Ring circumcision

novel device for adult male circumcision

Sponsors & Collaborators

  • EngenderHealth

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Mark Barone, DMD · EngenderHealth

  • Marc Goldstein, M.D. · Weill Medical College of Cornell University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
54 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-02-28
Completion
2010-03-31

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00993811 on ClinicalTrials.gov